参考文献

参考文献

［1］Almog N.Molecular mechanisms underlying tumour dormancy［J］.Cancer Lett，2010，294（2）：139-146.

［2］Balakrishnan S，Bhat F A，Raja Singh P，et al.Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition，angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer［J］.Cell Prolif，2016，49（6）：678-697.

［3］Biglia N，Bounous V E，Martincich L，et al.Role of MRI（magnetic resonance imaging）versus conventional imaging for breast cancer presurgical staging in young women or with dense breast［J］.Eur J Surg Oncol，2011，37（3）：199-204.

［4］Bignotti B，Signori A，Valdora F，et al.Evaluation of background parenchymal enhancement on breast MRI：a systematic review［J］.Br J Radiol，2017，90（1070）：20160542.

［5］Bockhorn M，Jain R K，Munn L L.Active versus passive mechanisms in metastasis：Do cancer cells crawl into vessels，or are they pushed［J］.Lancet Oncol，2007，8（5）：444-448.

［6］Chen Y，Keskin D，Sugimoto H，et al.Podoplanin+tumor lymphatics are rate limiting for breast cancer metastasis［J］.PLoS Biol，2018，16（12）：e2005907.

［7］Courtney M，Townsend R，Beauchamp D，et al.Mattox，Sabiston textbook of surgery：The Biological basis of modern surgical practice 19th ed［M］.Amsterdam：Elsevier，2016：883.

［8］Ferlay J，Soerjomataram I，Dikshit R，et al.Cancer incidence and mortality worldwide：sources，methods and major patterns in GLOBOCAN 2012［J］.Int J Cancer，2015，136（5）：E359-E386.

［9］Friedl P，Gilmour D.Collective cell migration in morphogenesis，regeneration and cancer［J］.Nat Rev Mol Cell Biol，2009，10（7）：445-457.

［10］Furlan A，Vercamer C，Heliot L，et al.Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells［J］.Int J Oncol，2019，54（1）：29-40.

［11］Gujam F J，Going J J，Edwards J，et al.The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer［J］.Crit Rev Oncol Hematol，2014，89（2）：231-241.

［12］Gujam F J，Going J J，Mohammed Z M，et al.Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer［J］.BMC Cancer，2014，14：676.

［13］Hon J D，Singh B，Sahin A，et al.Breast cancer molecular subtypes：from TNBC to QNBC［J］.Am J Cancer Res，2016，6（9）：1864-1872.

［14］Kadhim M A，Mayah A，Brooks S A.Does direct and indirect exposure to ionising radiation influence the metastatic potential of breast cancer cells［J］.Cancers（Basel），2020，12（1）：236.

［15］Kim M Y，Choi N，Yang J H，et al.Background parenchymal enhancement on breast MRI and mammographic breast density：correlation with tumour characteristics［J］.Clin Radiol，2015，70（7）：706-710.(https://www.daowen.com)

［16］Klingen T A，Chen Y，Stefansson I M，et al.Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival［J］.J Clin Pathol，2017，70（4）：313-319.

［17］Li J，Jiang Y，Chen C，et al.Integrin β4 is an effective and efficient marker in synchronously highlighting lymphatic and blood vascular invasion，and perineural aggression in malignancy［J］.Am J Surg Pathol，2020，44（5）：681-690.

［18］Li J，Mo Y，He B，et al.Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer［J］.Br J Radiol，2019，92（1103）：20190417.

［19］Mohammed R A，Menon S，Martin S G，et al.Prognostic significance of lymphatic invasion in lymph node-positive breast carcinoma：findings from a large case series with long-term follow-up using immunohist-ochemical endothelial marker［J］.Mod Pathol，2014，27（12）：1568-1577.

［20］Nash G F，Turner L F，Scully M F，et al.Platelets and Cancer.Lancet Oncol，2002，3（7）：425-430.

［21］Ozturk M，Polat A V，Sullu Y，et al.Background parenchymal enhancement and Fibroglandular tissue proportion on breast MRI：correlation with hormone receptor expression and molecular subtypes of breast cancer［J］.J Breast Health，2017，13（1）：27-33.

［22］Peters N H，BorelRinkes I H，Zuithoff N P，et al.Meta-Analysis of MR imaging in the diagnosis of breast lesions［J］.Radiology，2008，246（1）：116-124.

［23］Rajabi S，Dehghan M H，Dastmalchi R，et al.Therolesandrole-players in thyroid cancer angiogenesis［J］.Endocr J，2019，66（4）：277-293.

［24］Storr S J，Safuan S，Ahmad N，et al.Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro［J］.Cancer Immunol Immunother，2017，66（10）：1287-1294.

［25］Tremblay P L，Huot J，Auger F A.Mechanisms by which E-select inregulates diapedesis of colon cancer cells under flow conditions［J］.Cancer Res，2008，68（13）：5167-5176.

［26］Uzzan B，Nicolas P，Cucherat M，et al.Microvessel density as a prognostic factor in women with breast cancer：a systematic review of the literature and meta-analysis［J］.Cancer Res，2004，64（9）：2941-2955.

［27］Yaghjyan L，Colditz G A，Rosner B，et al.Mammographic breast density and breast cancer risk：interactions of percent density，absolute dense，and non-dense areas with breast cancer risk factors［J］.Breast Cancer Res Treat，2015，150（1）：181-189.

［28］Zhang F，Li T，Han L，et al.TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells［J］.Biochem Biophys Res Commun，2018，496（4）：1169-1175.

［29］Zhang S，Zhang D，Gong M，et al.High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer［J］.BMC Cancer，2017，17（1）：335.

［30］Zhao Y C，Ni X J，Li Y，et al.Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients［J］.World J Surg Oncol，2012，10：165.